Anteris Technologies Global Corp.

AVR ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024
Operating Activities
Net Income $-94.1M $-76.3M
Depreciation & Amortization $1.7M $1.5M
Depreciation $1.5M $1.3M
Amortization — —
Stock-Based Compensation $7.8M $6.5M
Net Cash from Operating Activities $-77.8M $-61.2M
Investing Activities
Capital Expenditures $2.0M $2.3M
Business Acquisitions — —
Net Cash from Investing Activities $-596.0K $-2.3M
Financing Activities
Dividends Paid — —
Stock Repurchases — —
Net Cash from Financing Activities $20.6M $112.8M
Net Change in Cash $-57.9M $49.4M
Free Cash Flow $-79.8M $-63.5M